EMA — authorised 30 May 2017
- Marketing authorisation holder: Biogen Idec Ltd
- Status: approved
🇪🇺 Spinraza in European Union
EMA authorised Spinraza on 30 May 2017
Marketing authorisation
Spinraza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in European Union
Frequently asked questions
Is Spinraza approved in European Union?
Yes. EMA authorised it on 30 May 2017.
Who is the marketing authorisation holder for Spinraza in European Union?
Biogen Idec Ltd holds the EU marketing authorisation.